The Global Immunoglobulin Market accounted for US$ 9.23 billion in 2020 and is estimated to be US$ 16.61 billion by 2030 and is anticipated to register a CAGR of 6.1%. Immunoglobulins are also known as antibodies, which are glycoprotein molecules produced by plasma cells. Immunoglobulin acts as critical part of immune response by specifically recognizing and binding to particular antigens, such as bacteria or viruses. Different classes of immunoglobulin include IgG, IgA, and IgM. Various immunological and neurological diseases can be treated by using these classes of immunoglobulin. This immunoglobulin’s can be administered intravenously and subcutaneously. The increasing application of immunoglobulin is gaining significant traction among pharmaceutical and biopharmaceutical companies for research and development.
The report “Global Immunoglobulin Market, By Product (IgG, IgA, IgM, IgE, and IgD), By Mode of Delivery (Intravenous and Subcutaneous), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) – Trends, Analysis and Forecast till 2030”
Key Highlights:
- In 2021, The U.S. FDA has approved the use of IVIG in various disorders. IVIG treatment is also used in many off-label prescription disorders, such as myasthenia gravis, multifocal motor neuropathy, and Guillain-Barre syndrome.
Analyst View:
The increasing number of geriatric population, which is more prone to develop disease due to low antibody immune response of body, is another factor propelling demand for immunoglobulin. However, stringent regulatory scenario, high cost of treatment, and emergence of alternative therapies is expected hamper growth of the immunoglobulin market in the near future.
Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Immunoglobulin Market, By Product (IgG, IgA, IgM, IgE, and IgD), By Mode of Delivery (Intravenous and Subcutaneous), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) – Trends, Analysis and Forecast till 2030”
To know the upcoming trends and insights prevalent in this market, click the link below:
https://www.prophecymarketinsights.com/market_insight/Global-Immunoglobulin-Market-By-Product-43
Key Market Insights from the report:
The Global Immunoglobulin Market accounted for US$ 9.23 billion in 2020 and is estimated to be US$ 16.61 billion by 2030 and is anticipated to register a CAGR of 6.1%. The Global Immunoglobulin Market report segments the market on the basis of product, mode of delivery and region.
- By Product, the Global Immunoglobulin Market is segmented into IgG, IgA, IgM, IgE, and IgD.
- By Mode of delivery, the Global Immunoglobulin Market is segmented into Intravenous and Subcutaneous.
- By region, the Global Immunoglobulin Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Competitive Landscape:
Key players operating in the global immunoglobulin market includes Baxter international Inc., CSL Ltd., Grifols S.A, Octapharma AG, Kedrion Biopharma Inc., LFB group, Biotest AG, China Biologics Products, Inc., BDI Pharma Inc., and Bayer Healthcare.
Other Topics: https://androidfun.fr/marche-du-zno-super-fin-analyse-regionale-et-analyse-technologique-jusquen-2030/
The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.
0
